A citation-based method for searching scientific literature

Rosa Parisi, Deborah P M Symmons, Christopher E M Griffiths, Darren M Ashcroft. J Invest Dermatol 2013
Times Cited: 1209







List of co-cited articles
534 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Psoriasis.
Wolf-Henning Boehncke, Michael P Schön. Lancet 2015
996
18

A systematic review of worldwide epidemiology of psoriasis.
I M Michalek, B Loring, S M John. J Eur Acad Dermatol Venereol 2017
289
12

Secukinumab in plaque psoriasis--results of two phase 3 trials.
Richard G Langley, Boni E Elewski, Mark Lebwohl, Kristian Reich, Christopher E M Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson,[...]. N Engl J Med 2014
12

Pathogenesis and clinical features of psoriasis.
Christopher Em Griffiths, Jonathan Nwn Barker. Lancet 2007
9

Psoriasis and comorbid diseases: Epidemiology.
Junko Takeshita, Sungat Grewal, Sinéad M Langan, Nehal N Mehta, Alexis Ogdie, Abby S Van Voorhees, Joel M Gelfand. J Am Acad Dermatol 2017
313
9

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
Kim A Papp, Richard G Langley, Mark Lebwohl, Gerald G Krueger, Philippe Szapary, Newman Yeilding, Cynthia Guzzo, Ming-Chun Hsu, Yuhua Wang, Shu Li,[...]. Lancet 2008
9

Definition of treatment goals for moderate to severe psoriasis: a European consensus.
U Mrowietz, K Kragballe, K Reich, P Spuls, C E M Griffiths, A Nast, J Franke, C Antoniou, P Arenberger, F Balieva,[...]. Arch Dermatol Res 2011
464
8

Immunology of psoriasis.
Michelle A Lowes, Mayte Suárez-Fariñas, James G Krueger. Annu Rev Immunol 2014
766
8

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
Leslie van der Fits, Sabine Mourits, Jane S A Voerman, Marius Kant, Louis Boon, Jon D Laman, Ferry Cornelissen, Anne-Marie Mus, Edwin Florencia, Errol P Prens,[...]. J Immunol 2009
8

Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.
Joel M Gelfand, Rachel Weinstein, Steven B Porter, Andrea L Neimann, Jesse A Berlin, David J Margolis. Arch Dermatol 2005
402
7

Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study.
D A Springate, R Parisi, E Kontopantelis, D Reeves, C E M Griffiths, D M Ashcroft. Br J Dermatol 2017
91
7

Psoriasis prevalence among adults in the United States.
Tara D Rachakonda, Clayton W Schupp, April W Armstrong. J Am Acad Dermatol 2014
434
7

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Kenneth B Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim A Papp, Howard Sofen, Lluís Puig, Peter Foley,[...]. Lancet 2018
209
7

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).
Craig L Leonardi, Alexa B Kimball, Kim A Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T Dooley, Kenneth B Gordon. Lancet 2008
7

Psoriasis.
Frank O Nestle, Daniel H Kaplan, Jonathan Barker. N Engl J Med 2009
7

Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.
Mark G Lebwohl, Hervé Bachelez, Jonathan Barker, Giampiero Girolomoni, Arthur Kavanaugh, Richard G Langley, Carle F Paul, Lluís Puig, Kristian Reich, Peter C M van de Kerkhof. J Am Acad Dermatol 2014
287
6

National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study.
Rosa Parisi, Ireny Y K Iskandar, Evangelos Kontopantelis, Matthias Augustin, Christopher E M Griffiths, Darren M Ashcroft. BMJ 2020
70
8



Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth Gordon, Jolanta Weglowska, Lluis Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco Kerdel,[...]. N Engl J Med 2015
452
6

Psoriasis Pathogenesis and Treatment.
Adriana Rendon, Knut Schäkel. Int J Mol Sci 2019
260
6

The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis.
Cristina Albanesi, Stefania Madonna, Paolo Gisondi, Giampiero Girolomoni. Front Immunol 2018
136
5

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Alan Menter, Alice Gottlieb, Steven R Feldman, Abby S Van Voorhees, Craig L Leonardi, Kenneth B Gordon, Mark Lebwohl, John Y M Koo, Craig A Elmets, Neil J Korman,[...]. J Am Acad Dermatol 2008
830
5

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
Kim A Papp, Andrew Blauvelt, Michael Bukhalo, Melinda Gooderham, James G Krueger, Jean-Philippe Lacour, Alan Menter, Sandra Philipp, Howard Sofen, Stephen Tyring,[...]. N Engl J Med 2017
254
5

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.
Diamant Thaçi, Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, Francisco Vanaclocha, Külli Kingo, Michael Ziv, Andreas Pinter, Sophie Hugot, Ruquan You,[...]. J Am Acad Dermatol 2015
334
5

The Genetic Basis of Psoriasis.
Francesca Capon. Int J Mol Sci 2017
72
6

The Inflammatory Response in Psoriasis: a Comprehensive Review.
Yaxiong Deng, Christopher Chang, Qianjin Lu. Clin Rev Allergy Immunol 2016
161
5

Severe psoriasis--oral therapy with a new retinoid.
T Fredriksson, U Pettersson. Dermatologica 1978
5

The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis.
G Girolomoni, R Strohal, L Puig, H Bachelez, J Barker, W H Boehncke, J C Prinz. J Eur Acad Dermatol Venereol 2017
105
5

Psoriasis and Obesity.
Peter Jensen, Lone Skov. Dermatology 2016
68
7

Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.
Michelle A Lowes, Toyoko Kikuchi, Judilyn Fuentes-Duculan, Irma Cardinale, Lisa C Zaba, Asifa S Haider, Edward P Bowman, James G Krueger. J Invest Dermatol 2008
702
5

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis.
K A Papp, K Reich, C Paul, A Blauvelt, W Baran, C Bolduc, D Toth, R G Langley, J Cather, A B Gottlieb,[...]. Br J Dermatol 2016
252
5

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
Alan Menter, Bruce E Strober, Daniel H Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W Armstrong, Cody Connor, Kelly M Cordoro, Dawn M R Davis,[...]. J Am Acad Dermatol 2019
208
5

Critical role of environmental factors in the pathogenesis of psoriasis.
Jinrong Zeng, Shuaihantian Luo, Yumeng Huang, Qianjin Lu. J Dermatol 2017
74
6

Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants.
Lam C Tsoi, Philip E Stuart, Chao Tian, Johann E Gudjonsson, Sayantan Das, Matthew Zawistowski, Eva Ellinghaus, Jonathan N Barker, Vinod Chandran, Nick Dand,[...]. Nat Commun 2017
114
5

Pathogenesis and therapy of psoriasis.
Michelle A Lowes, Anne M Bowcock, James G Krueger. Nature 2007
5


The global state of psoriasis disease epidemiology: a workshop report.
C E M Griffiths, J M van der Walt, D M Ashcroft, C Flohr, L Naldi, T Nijsten, M Augustin. Br J Dermatol 2017
62
6

Prevalence of psoriasis in Spain (Epiderma Project: phase I).
C Ferrándiz, X Bordas, V García-Patos, S Puig, R Pujol, A Smandía. J Eur Acad Dermatol Venereol 2001
116
4

Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.
Howa Yeung, Junko Takeshita, Nehal N Mehta, Stephen E Kimmel, Alexis Ogdie, David J Margolis, Daniel B Shin, Rosemary Attor, Andrea B Troxel, Joel M Gelfand. JAMA Dermatol 2013
284
4



European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.
A Nast, P Gisondi, A D Ormerod, P Saiag, C Smith, P I Spuls, P Arenberger, H Bachelez, J Barker, E Dauden,[...]. J Eur Acad Dermatol Venereol 2015
250
4

Psoriasis and comorbid diseases: Implications for management.
Junko Takeshita, Sungat Grewal, Sinéad M Langan, Nehal N Mehta, Alexis Ogdie, Abby S Van Voorhees, Joel M Gelfand. J Am Acad Dermatol 2017
78
5

Cytokines in psoriasis.
Jaymie Baliwag, Drew H Barnes, Andrew Johnston. Cytokine 2015
173
4

Incidence and Prevalence of Psoriasis in Denmark.
Alexander Egeberg, Lone Skov, Gunnar H Gislason, Jacob P Thyssen, Lotus Mallbris. Acta Derm Venereol 2017
38
10

Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction.
Robert S Stern, Tamar Nijsten, Steven R Feldman, David J Margolis, Tara Rolstad. J Investig Dermatol Symp Proc 2004
513
4

Risk of myocardial infarction in patients with psoriasis.
Joel M Gelfand, Andrea L Neimann, Daniel B Shin, Xingmei Wang, David J Margolis, Andrea B Troxel. JAMA 2006
4

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.
Craig A Elmets, Craig L Leonardi, Dawn M R Davis, Joel M Gelfand, Jason Lichten, Nehal N Mehta, April W Armstrong, Cody Connor, Kelly M Cordoro, Boni E Elewski,[...]. J Am Acad Dermatol 2019
96
4

Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.
Craig Leonardi, Robert Matheson, Claus Zachariae, Gregory Cameron, Linda Li, Emily Edson-Heredia, Daniel Braun, Subhashis Banerjee. N Engl J Med 2012
693
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.